Jared R. Brosch

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Stephen Salloway, Martin R. Farlow, Eric McDade et al. · Nature Medicine · 2021 · 349 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Alzheimer's Disease +9

Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers

Brian A. Gordon, Tyler Blazey, Jon Christensen et al. · Brain · 2019 · 173 citations · Full text

Aging, Neurochemical Biomarkers, Tau Tracer +20

Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies

Yi Su, Shaney Flores, Guoqiao Wang et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2019 · 130 citations · Full text

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 130 citations · Full text

Clinical Trials, Progressive Supranuclear Palsy, Placebo-controlled Trial +7

A novel <i>SNCA</i> E83Q mutation in a case of dementia with Lewy bodies and atypical frontotemporal lobar degeneration

Alifiya Kapasi, Jared R. Brosch, Kelly Nudelman et al. · Neuropathology · 2020 · 79 citations · Full text